This article is part of the supplement: Update on therapeutic temperature management

Meeting abstract

Hypothermia in cardiogenic shock

Jesper van der Pals

  • Correspondence: Jesper van der Pals

Author Affiliations

Department of Cardiology, Lund University, Skane University Hospital, Sweden

Critical Care 2012, 16(Suppl 2):A21 doi:10.1186/cc11279


The electronic version of this article is the complete one and can be found online at: http://ccforum.com/content/16/S2/A21


Published:7 June 2012

© 2012 van der Pals; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Meeting abstract

Cardiogenic shock is a state of inadequate systemic tissue perfusion, despite adequate left ventricular filling pressure. It is caused by extensive myocardial damage and appears to be aggravated by a systemic inflammatory response [1-4]. The result is hypotension with metabolic acidosis and often a fatal outcome. The condition affects approximately 5% of the patients with myocardial infarction, and carries a dismal prognosis if it prevails after reperfusion.

Therapeutic hypothermia has several properties of potential benefit in cardiogenic shock: Experiments with isolated myofibrils, papillary muscles and cross-circulated hearts have demonstrated that mild hypothermia increases myocardial contractility [5-7]. In the in vivo heart, mild hypothermia has been found to increase stroke volume and cardiac output [6,8].

The increase in contractility is considered to be mediated by an increased myofilament sensitivity to existing Ca2+, without a corresponding increase in myocardial oxygen consumption [9]. Moreover, hypothermia reduces the metabolic rate with 5 to 7%/°C [10,11], thereby reducing the demand on the circulation from the peripheral tissues. In an experimental setting, it also has the ability to reduce infarct size if applied prior to reperfusion [12,13].

In dog-based and porcine-based models of cardiogenic shock secondary to ischemia, therapeutic hypothermia has improved hemodynamic and metabolic parameters, and reduced mortality [14,15]. No randomized controlled trials of therapeutic hypothermia in cardiogenic shock in humans exist, but case series indicate that the effects observed in animal experiments can be reproduced [16-19].

In conclusion, therapeutic hypothermia is a promising treatment option for patients in cardiogenic shock that warrants further investigation.

References

  1. Hochman JS: Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.

    Circulation 2003, 107:2998-3002. PubMed Abstract | Publisher Full Text OpenURL

  2. Kaluski E, Hendler A, Blatt A, Uriel N: Nitric oxide synthase inhibitors in post-myocardial infarction cardiogenic shock - an update.

    Clin Cardiol 2006, 29:482-488. PubMed Abstract | Publisher Full Text OpenURL

  3. Cotter G, Berger PB: Cardiogenic shock - beyond the large infarction.

    Crit Care Med 2006, 34:2234-2235. PubMed Abstract | Publisher Full Text OpenURL

  4. Geppert A, Dorninger A, Delle-Karth G, Zorn G, Heinz G, Huber K: Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction.

    Crit Care Med 2006, 34:2035-2042. PubMed Abstract | Publisher Full Text OpenURL

  5. Bjornstad H, Tande PM, Refsum H: Mechanisms for hypothermia-induced increase in contractile force studied by mechanical restitution and post-rest contractions in guinea-pig papillary muscle.

    Acta Physiol Scand 1993, 148:253-264. PubMed Abstract | Publisher Full Text OpenURL

  6. Weisser J, Martin J, Bisping E, Maier LS, Beyersdorf F, Hasenfuss G, Pieske B: Influence of mild hypothermia on myocardial contractility and circulatory function.

    Basic Res Cardiol 2001, 96:198-205. PubMed Abstract | Publisher Full Text OpenURL

  7. Mattheussen M, Mubagwa K, Van Aken H, Wusten R, Boutros A, Flameng W: Interaction of heart rate and hypothermia on global myocardial contraction of the isolated rabbit heart.

    Anesth Analg 1996, 82:975-981. PubMed Abstract | Publisher Full Text OpenURL

  8. Nishimura Y, Naito Y, Nishioka T, Okamura Y: The effects of cardiac cooling under surface-induced hypothermia on the cardiac function in the in situ heart.

    Interact Cardiovasc Thorac Surg 2005, 4:101-105. PubMed Abstract | Publisher Full Text OpenURL

  9. Suga H, Goto Y, Igarashi Y, Yasumura Y, Nozawa T, Futaki S, Tanaka N: Cardiac cooling increases Emax without affecting relation between O2 consumption and systolic pressure-volume area in dog left ventricle.

    Circ Res 1988, 63:61-71. PubMed Abstract | Publisher Full Text OpenURL

  10. Polderman KH: Mechanisms of action, physiological effects, and complications of hypothermia.

    Critical Care Med 2009, 37:S186-S202. Publisher Full Text OpenURL

  11. Polderman KH: Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality - Part 2: practical aspects and side effects.

    Intensive Care Med 2004, 30:757-769. PubMed Abstract | Publisher Full Text OpenURL

  12. Gotberg M, Olivecrona GK, Koul S, Carlsson M, Engblom H, Ugander M, van der Pals J, Algotsson L, Arheden H, Erlinge D: A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction.

    Circ Cardiovasc Interv 2010, 3:400-407. PubMed Abstract | Publisher Full Text OpenURL

  13. Götberg M M, Olivecrona GK, Engblom H, Ugander M, van der Pals J, Heiberg E, Arheden H, Erlinge D: Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size.

    BMC Cardiovasc Disord 2008, 8:7. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  14. Gotberg M, van der Pals J, Olivecrona GK, Koul S, Erlinge D: Mild hypothermia reduces acute mortality and improves hemodynamic outcome in a cardiogenic shock pig model.

    Resuscitation 2010, 81:1190-1196. PubMed Abstract | Publisher Full Text OpenURL

  15. Boyer NH, Gerstein MM: Induced hypothermia in dogs with acute myocardial infarction and shock.

    J Thorac Cardiovasc Surg 1977, 74:286-294. PubMed Abstract OpenURL

  16. Skulec R, Kovarnik T, Dostalova G, Kolar J, Linhart A: Induction of mild hypothermia in cardiac arrest survivors presenting with cardiogenic shock syndrome.

    Acta Anaesthesiol Scand 2008, 52:188-194. PubMed Abstract | Publisher Full Text OpenURL

  17. Hovdenes J, Laake JH, Aaberge L, Haugaa H, Bugge JF: Therapeutic hypothermia after out-of-hospital cardiac arrest: experiences with patients treated with percutaneous coronary intervention and cardiogenic shock.

    Acta Anaesthesiol Scand 2007, 51:137-142. PubMed Abstract | Publisher Full Text OpenURL

  18. Yahagi N, Kumon K, Watanabe Y, Tanigami H, Haruna M, Hayashi H, Imanaka H, Takeuchi M, Ohashi Y, Takamoto S: Value of mild hypothermia in patients who have severe circulatory insufficiency even after intra-aortic balloon pump.

    J Clin Anesth 1998, 10:120-125. PubMed Abstract | Publisher Full Text OpenURL

  19. Moriyama Y, Iguro Y, Shimokawa S, Saigenji H, Toyohira H, Taira A: Successful application of hypothermia combined with intra-aortic balloon pump support to low-cardiac-output state after open heart surgery.

    Angiology 1996, 47:595-599. PubMed Abstract | Publisher Full Text OpenURL